Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer

This publication has 18 references indexed in Scilit:

• Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer
  Journal of Urology, 1996
• bcl-2 Expression, p53 Accumulation, and Apoptosis in Ovarian Carcinomas
  American Journal of Clinical Pathology, 1996
• Purification and Characterization of the Bcl-2 Protein
  Archives of Biochemistry and Biophysics, 1994
• Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.
  Proceedings of the National Academy of Sciences, 1994
• The mdm-2 gene is induced in response to UV light in a p53-dependent manner.
  Proceedings of the National Academy of Sciences, 1993
• Apoptosis and disease
  The Lancet, 1993
• Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
  Blood, 1993
• P53 in tumour pathology: Can we trust immunocytochemistry?
  The Journal of Pathology, 1992
• Drug-target interactions: only the first step in the commitment to a programmed cell death?
  British Journal of Cancer, 1991
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
  Nature, 1988